KRATOS DEFENSE ($KTOS) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.12 per share, beating estimates of $0.09 by $0.03. The company also reported revenue of $302,600,000, beating estimates of $298,767,832 by $3,832,168.
You can see Quiver Quantitative's $KTOS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KRATOS DEFENSE Insider Trading Activity
KRATOS DEFENSE insiders have traded $KTOS stock on the open market 47 times in the past 6 months. Of those trades, 1 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $KTOS stock by insiders over the last 6 months:
- PHILLIP D CARRAI (President, STC Division) has made 0 purchases and 6 sales selling 45,000 shares for an estimated $1,257,275.
- STEVEN S. FENDLEY (President, US Division) has made 0 purchases and 6 sales selling 42,000 shares for an estimated $1,211,956.
- DEANNA H LUND (EVP & CFO) has made 0 purchases and 6 sales selling 36,000 shares for an estimated $1,054,687.
- STACEY G ROCK (President, KTT Division) has made 0 purchases and 9 sales selling 24,000 shares for an estimated $713,066.
- DAVID M CARTER (President, DRSS Division) has made 0 purchases and 6 sales selling 24,000 shares for an estimated $703,166.
- THOMAS E IV MILLS (President, C5ISR Division) has made 0 purchases and 4 sales selling 23,153 shares for an estimated $638,499.
- DE BURGREEN MARIA CERVANTES (VP & Corp. Controller) has made 0 purchases and 2 sales selling 19,528 shares for an estimated $585,840.
- ERIC M DEMARCO (President & CEO) purchased 9,500 shares for an estimated $250,322
- MARIE MENDOZA (SVP & General Counsel) has made 0 purchases and 5 sales selling 7,415 shares for an estimated $218,844.
- BENJAMIN M. GOODWIN (SVP Corp. Dev. & Gov. Affairs) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $138,541.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KRATOS DEFENSE Hedge Fund Activity
We have seen 185 institutional investors add shares of KRATOS DEFENSE stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 11,605,372 shares (+88.3%) to their portfolio in Q1 2025, for an estimated $344,563,494
- ROVIDA ADVISORS INC. removed 1,773,655 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $46,789,018
- PRINCIPAL FINANCIAL GROUP INC added 987,408 shares (+9709.0%) to their portfolio in Q1 2025, for an estimated $29,316,143
- LORD, ABBETT & CO. LLC added 934,455 shares (+140.5%) to their portfolio in Q4 2024, for an estimated $24,650,922
- VOYA INVESTMENT MANAGEMENT LLC added 767,345 shares (+435.3%) to their portfolio in Q4 2024, for an estimated $20,242,561
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 739,821 shares (-23.8%) from their portfolio in Q4 2024, for an estimated $19,516,477
- VANGUARD GROUP INC added 701,216 shares (+5.0%) to their portfolio in Q4 2024, for an estimated $18,498,078
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KRATOS DEFENSE Government Contracts
We have seen $386,032 of award payments to $KTOS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- NSNS: 2540-01-644-3965, 5985-01-644-1054, 6105-01-656-0530: $334,776
- NSN 6105-01-6560-0018: $43,395
- QTY 4 CLIN 5006: $7,860
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
KRATOS DEFENSE Analyst Ratings
Wall Street analysts have issued reports on $KTOS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Outperform" rating on 02/04/2025
- RBC Capital issued a "Outperform" rating on 01/06/2025
To track analyst ratings and price targets for KRATOS DEFENSE, check out Quiver Quantitative's $KTOS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
